197 related articles for article (PubMed ID: 22438973)
1. Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC.
Sun W; Zaboli D; Liu Y; Arnaoutakis D; Khan T; Wang H; Koch W; Khan Z; Califano JA
PLoS One; 2012; 7(3):e33642. PubMed ID: 22438973
[TBL] [Abstract][Full Text] [Related]
2. Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer.
Sun W; Zaboli D; Wang H; Liu Y; Arnaoutakis D; Khan T; Khan Z; Koch WM; Califano JA
Clin Cancer Res; 2012 Feb; 18(4):1082-91. PubMed ID: 22228635
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients.
Rettori MM; de Carvalho AC; Bomfim Longo AL; de Oliveira CZ; Kowalski LP; Carvalho AL; Vettore AL
Carcinogenesis; 2013 Jan; 34(1):20-7. PubMed ID: 23042095
[TBL] [Abstract][Full Text] [Related]
5. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance.
Carvalho AL; Henrique R; Jeronimo C; Nayak CS; Reddy AN; Hoque MO; Chang S; Brait M; Jiang WW; Kim MM; Claybourne Q; Goldenberg D; Khan Z; Khan T; Westra WH; Sidransky D; Koch W; Califano JA
Clin Cancer Res; 2011 Jul; 17(14):4782-9. PubMed ID: 21628494
[TBL] [Abstract][Full Text] [Related]
6. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
[TBL] [Abstract][Full Text] [Related]
7. Validation of methylation markers for diagnosis of oral cavity cancer.
Arantes LM; de Carvalho AC; Melendez ME; Centrone CC; Góis-Filho JF; Toporcov TN; Caly DN; Tajara EH; Goloni-Bertollo EM; Carvalho AL;
Eur J Cancer; 2015 Mar; 51(5):632-41. PubMed ID: 25686481
[TBL] [Abstract][Full Text] [Related]
8. TIMP3 and CCNA1 hypermethylation in HNSCC is associated with an increased incidence of second primary tumors.
Rettori MM; de Carvalho AC; Longo AL; de Oliveira CZ; Kowalski LP; Carvalho AL; Vettore AL
J Transl Med; 2013 Dec; 11():316. PubMed ID: 24359512
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma.
Krajnović M; Radojković M; Davidović R; Dimitrijević B; Krtolica K
Med Oncol; 2013 Mar; 30(1):441. PubMed ID: 23275143
[TBL] [Abstract][Full Text] [Related]
10. Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma.
Rastetter M; Schagdarsurengin U; Lahtz C; Fiedler E; Marsch WCh; Dammann R; Helmbold P
Histol Histopathol; 2007 Sep; 22(9):1005-15. PubMed ID: 17523078
[TBL] [Abstract][Full Text] [Related]
11. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
12. DNA content and methylation of p16, DAPK and RASSF1A gene in tumour and distant, normal mucosal tissue of head and neck squamous cell carcinoma patients.
Laytragoon-Lewin N; Chen F; Castro J; Elmberger G; Rutqvist LE; Lewin F; Turesson I; Lundgren J
Anticancer Res; 2010 Nov; 30(11):4643-8. PubMed ID: 21115918
[TBL] [Abstract][Full Text] [Related]
13. KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses.
Demokan S; Chang X; Chuang A; Mydlarz WK; Kaur J; Huang P; Khan Z; Khan T; Ostrow KL; Brait M; Hoque MO; Liegeois NJ; Sidransky D; Koch W; Califano JA
Int J Cancer; 2010 Nov; 127(10):2351-9. PubMed ID: 20162572
[TBL] [Abstract][Full Text] [Related]
14. DAPK promoter hypermethylation in tissues and body fluids of oral precancer patients.
Liu Y; Zhou ZT; He QB; Jiang WW
Med Oncol; 2012 Jun; 29(2):729-33. PubMed ID: 21516484
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA
Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258
[TBL] [Abstract][Full Text] [Related]
16. Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes.
Su Y; Xu H; Xu Y; Yu J; Xian Y; Luo Q
Hematology; 2012 Jan; 17(1):41-6. PubMed ID: 22549447
[TBL] [Abstract][Full Text] [Related]
17. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.
Buckingham L; Penfield Faber L; Kim A; Liptay M; Barger C; Basu S; Fidler M; Walters K; Bonomi P; Coon J
Int J Cancer; 2010 Apr; 126(7):1630-9. PubMed ID: 19795445
[TBL] [Abstract][Full Text] [Related]
18. Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression.
Iliopoulos D; Oikonomou P; Messinis I; Tsezou A
Oncol Rep; 2009 Jul; 22(1):199-204. PubMed ID: 19513524
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.
Pierini S; Jordanov SH; Mitkova AV; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
Head Neck; 2014 Aug; 36(8):1103-8. PubMed ID: 23804521
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
